PDCO feedback late 3Q but i wouldn’t expect EMA IIa trial approval until Q4 ….. As long as first pt dosed by xmas timeline remains about right.
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
